Study on Early Lyme Neuroborreliosis

University Medical Centre Ljubljana

Status: Unknown

Conditions: Nervous System Lyme Borreliosis

Treatments: Drug: ceftriaxone

Study type: Interventional

Funder types: Other

Identifiers

NCT00910533

LNB-0509

Details and patient eligibility

About

The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.

Enrollment: 50 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• erythema migrans within 4 months before neurologic involvement and pleocytosis in patients >15 years old

Exclusion criteria

• pregnancy
• lactation
• history of adverse reaction to a beta-lactam antibiotic

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Early Lyme neuroborreliosis patients

Active Comparator group

Treatment:

Drug: ceftriaxone

control subjects

No Intervention group

Description:

Control subjects without a history of Lyme borreliosis.